REXZARLIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Sept 2026)
What this means for you
This application is over — abandoned 14 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 99248630
- Mark type
- Stylized text
- Filed
- 23 Jun 2025
- Published for opposition
- 16 Dec 2025
- Abandoned
- 14 Sept 2026
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders.
Owner
- Juno Therapeutics, Inc., Seattle, WA, US
- Juno Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 14 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2025 — ASSIGNED TO EXAMINER
- 23 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 23 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Jun 2025 — NEW APPLICATION ENTERED